New Zealand pioneering downscheduling: Gauld

With last year’s reclassification of sildenafil, New Zealand reinforced its reputation as an innovator in down-scheduling medicines from prescription to non-prescription status, says ASMI. International switch expert Dr Natalie Gauld (pictured), who will speak at ASMI’s Conference on 11 November 2015, has led research showing that New Zealand, like the United Kingdom, has been open